Optima Health Exceeds Profit Forecasts by 10% Due to Strong Second Half and Acquisition
Optima Health PLC (OPT, OHLTF, J3N) exceeded full-year adjusted EBITDA forecasts by around 10%, driven by a strong second-half performance and the completion of the PAM acquisition. The company aims for £200 million in revenue and £40 million in adjusted EBITDA over the medium term, with the acquisition expected to help achieve these targets.
Topics: acquisition earnings EBITDA profit revenue strategic growth